Affiliation:
1. Department of Nuclear Medicine, West China Hospital, Sichuan University and
2. Mental Health Center, West China Hospital of Sichuan University, Chengdu, Sichuan, PR China
Abstract
Objectives
Our main aim was to explore whether cognitive behavior therapy based on the health education pathway (CBT-HEP) can effectively alleviate the distress, anxiety, and depression of papillary thyroid carcinoma (PTC) patients after 131I treatment. In addition, we investigated the critical factors that can significantly affect the distress and quality of life in PTC patients before 131I treatment.
Methods
In total, 496 people were screened and 357 were enrolled, followed by randomization of those with a distress thermometer (DT) ≥4. Patients in the experimental group received CBT-HEP intervention, and patients in the control group were given casual conversation.
Results
The scores of DT, Hamilton Anxiety Scale (HAMA) and Patient Health Questionnaire-9 (PHQ-9) in CBT-HEP group decreased gradually after intervention. In control group, DT scores decreased significantly, while HAMA and PHQ-9 scores did not change significantly.
Conclusion
CBT-HEP is effective in relieving distress, anxiety and depression in PTC patients. In addition, female sex, lifestyle, hypothyroidism, negative emotions, related symptoms, fear of tumor recurrence and radiation safety are the critical factors affecting mental health and quality of life.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference25 articles.
1. Mental health and cancer: why it is time to innovate and integrate-a call to action.;Fernando;Eur Urol Focus,2020
2. Health, health-related quality of life, and quality of life: what is the difference?;Karimi;PharmacoEcon,2016
3. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States.;Rahib;Cancer Res,2014
4. Thyroid cancer mortality and incidence: a global overview.;La Vecchia;Int J Cancer,2015
5. Cancer treatment and survivorship statistics, 2016.;Miller;CA Cancer J Clin,2016